申请人:The Upjohn Company
公开号:US05116981A1
公开(公告)日:1992-05-26
This invention encompasses novel analogs of Leukotriene B.sub.4 which are selected from a compound of formula I, B--C.apprxeq.C--CH.sub.2 C(M.sub.2)--C.apprxeq.C--Y--C(M.sub.1)--A, or formula II, B--C.apprxeq.C--CH.sub.2 C(M.sub.2)--C.apprxeq.C--P--R.sub.5 --A: wherein Y is: ##STR1## wherein P is: ##STR2## Patentable intermediates, process for making the novel analogs and intermediates and preparation of useful pharmacological agents comprising the analogs and intermediates are part of this invention.
本发明涵盖了Leukotriene B.sub.4的新型类似物,所选自化合物的公式I,B--C.apprxeq.C--CH.sub.2 C(M.sub.2)--C.apprxeq.C--Y--C(M.sub.1)--A,或者公式II,B--C.apprxeq.C--CH.sub.2 C(M.sub.2)--C.apprxeq.C--P--R.sub.5 --A:其中Y为:##STR1## 其中P为:##STR2## 本发明还涉及可专利化的中间体,制备新型类似物和中间体的过程以及制备包括类似物和中间体的有用药理制剂。